Latest Regulatory Approvals News

Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.

Magnetic Resources NL has secured a pivotal native title agreement with the Wangkatja Tjungula Aboriginal Corporation, removing key regulatory hurdles for the Lady Julie Gold Project in Western Australia.

Centuria Capital Group has announced a fully franked ordinary dividend of AUD 0.052 per security for the six months ending June 30, 2025, payable on August 19, 2025. This steady payout underscores the group's ongoing commitment to delivering shareholder value amid a stable property investment environment.

Javelin Minerals is fast-tracking mining at its Eureka Gold Project, targeting 34,000 recoverable ounces from a granted Mining Lease within 12 months. Advanced contractor talks and promising drilling results underpin this push in a buoyant gold price environment.

C29 Metals has secured Category 4 exploration approval for its newly granted eastern tenement in Kazakhstan, advancing its multi-mineral project and gaining strong local community support.

Alkane Resources has secured Swedish regulatory approval for its proposed merger with Mandalay Resources, advancing a significant consolidation in the gold and antimony mining sector. The deal now awaits further approvals before shareholder votes expected in July.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

Codeifai Limited has agreed to acquire its main competitor Trust Codes Global Limited, significantly expanding its footprint and product capabilities ahead of the 2027 global shift to 2D barcodes.

Karoon Energy has successfully acquired 100% interests in six offshore blocks in Brazil’s Santos Basin, reinforcing its strategic position and increasing its 2025 capital expenditure guidance to US$120-140 million.

Blaze Minerals has inked a binding deal to acquire a major interest in the Loulombo Base Metals Project in the Republic of Congo, backed by a $2.52 million capital raise to fund exploration and development.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a significant supply agreement to enter Germany’s burgeoning medical cannabis market, promising at least A$5.6 million in revenue for FY2026.